Yahoo Web Search

Search results

    • Small Business - Picayune Item | Picayune Item

      The Picayune Item· 5 days ago

      Eli Lilly and Company (NYSE: LLY) announced detailed results from SYNERGY-NASH, a phase 2 study of 190 patients, with or without type 2 diabetes, to evaluate the investigational use of tirzepatide ...

    • Coping With Graft-Versus-Host-Disease

      Coping With Graft-Versus-Host-Disease

      Verywell Health via Yahoo News· 2 days ago

      Learn how to cope with your graft-versus-host-disease day-to-day, including how to eat to reduce symptoms, exercise, manage finances, and find support.